drugset / Trial / NCT00362245

Amikacin Penetration Into the Cerebrospinal Fluid

NCT00362245

Phase 4 Withdrawn Rambam Health Care Campus
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The limited available data precludes establishing an antibiotic regimen in patients suffering from bacterial meningitis after head trauma, or spontaneous bleeding Understanding the disposition of Amikacin administered intrathecally will enable to propose rational treatment of these patients.

Timeline

Start
2006-09
Primary completion
2008-11
Completion
2008-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Amikacin Small molecule Intrathecal